Literature DB >> 12654844

Cloning and characterization of an Ehrlichia canis gene encoding a protein localized to the morula membrane.

Ching-Hao Teng1, Raghavan U M Palaniappan, Yung-Fu Chang.   

Abstract

A gene encoding a 23.5-kDa ehrlichial morula membrane protein designated MmpA was cloned by screening an Ehrlichia canis expression library with convalescent dog sera, which resulted in three positive clones. Sequence analysis of the insert DNAs from all three clones indicated an open reading frame with a size of 666 bp that encodes MmpA. The structural analysis of MmpA indicated that it is a transmembrane protein with extreme hydrophobicity. Southern blot analysis of the HindIII-digested chromosomal DNA demonstrated the presence of a single copy of the mmpA gene in E. canis and Ehrlichia chaffeensis but not in the human granulocytic ehrlichiosis agent. The mmpA gene was amplified, cloned, and expressed as a fusion protein. Polyclonal antibodies to the recombinant protein (rMmpA) were raised in rabbits. Western blot analysis of E. canis and E. chaffeensis lysates with the anti-rMmpA serum resulted in the presence of an MmpA band only in E. canis, not in E. chaffeenesis. Sera from dogs which were either naturally or experimentally infected with E. canis recognized the recombinant protein. Double immunofluorescence confocal microscopy studies demonstrated that MmpA was localized mainly on the morula membrane of E. canis. Since the morula membrane is the interface between the ehrlichial growing environment and the host cytoplasm, MmpA may play a role in bacterium-host cell interactions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654844      PMCID: PMC152100          DOI: 10.1128/IAI.71.4.2218-2225.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  pHG165: a pBR322 copy number derivative of pUC8 for cloning and expression.

Authors:  G S Stewart; S Lubinsky-Mink; C G Jackson; A Cassel; J Kuhn
Journal:  Plasmid       Date:  1986-05       Impact factor: 3.466

2.  Human infection with Ehrlichia canis, a leukocytic rickettsia.

Authors:  K Maeda; N Markowitz; R C Hawley; M Ristic; D Cox; J E McDade
Journal:  N Engl J Med       Date:  1987-04-02       Impact factor: 91.245

3.  Prediction of protein antigenic determinants from amino acid sequences.

Authors:  T P Hopp; K R Woods
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

4.  Escherichia coli promoter sequences predict in vitro RNA polymerase selectivity.

Authors:  M E Mulligan; D K Hawley; R Entriken; W R McClure
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

5.  Distribution of Ehrlichia canis among military working dogs in the world and selected civilian dogs in the United States.

Authors:  T J Keefe; C J Holland; P E Salyer; M Ristic
Journal:  J Am Vet Med Assoc       Date:  1982-08-01       Impact factor: 1.936

6.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

7.  Chlamydia trachomatis IncA is localized to the inclusion membrane and is recognized by antisera from infected humans and primates.

Authors:  J P Bannantine; W E Stamm; R J Suchland; D D Rockey
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Nucleotide sequence of the luxB gene of Vibrio harveyi and the complete amino acid sequence of the beta subunit of bacterial luciferase.

Authors:  T C Johnston; R B Thompson; T O Baldwin
Journal:  J Biol Chem       Date:  1986-04-15       Impact factor: 5.157

9.  Kinetics of antibody response to Ehrlichia canis assayed by the indirect fluorescent antibody method.

Authors:  R M Weisiger; M Ristic; D L Huxsoll
Journal:  Am J Vet Res       Date:  1975-05       Impact factor: 1.156

10.  Tropical canine pancytopenia: Clinical, hematologic, and serologic response of dogs to Ehrlichia canis infection, tetracycline therapy, and challenge inoculation.

Authors:  W C Buhles; D L Huxsoll; M Ristic
Journal:  J Infect Dis       Date:  1974-10       Impact factor: 5.226

View more
  4 in total

1.  Escherichia coli K1 RS218 interacts with human brain microvascular endothelial cells via type 1 fimbria bacteria in the fimbriated state.

Authors:  Ching-Hao Teng; Mian Cai; Sooan Shin; Yi Xie; Kee-Jun Kim; Naveed Ahmed Khan; Francescopaolo Di Cello; Kwang Sik Kim
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

2.  Inclusion membrane proteins of Protochlamydia amoebophila UWE25 reveal a conserved mechanism for host cell interaction among the Chlamydiae.

Authors:  Eva Heinz; Daniel D Rockey; Jacqueline Montanaro; Karin Aistleitner; Michael Wagner; Matthias Horn
Journal:  J Bacteriol       Date:  2010-07-30       Impact factor: 3.490

3.  NlpI facilitates deposition of C4bp on Escherichia coli by blocking classical complement-mediated killing, which results in high-level bacteremia.

Authors:  Yu-ting Tseng; Shainn-Wei Wang; Kwang Sik Kim; Ying-Hsiang Wang; Yufeng Yao; Chien-Cheng Chen; Chi-Wu Chiang; Pao-Chuan Hsieh; Ching-Hao Teng
Journal:  Infect Immun       Date:  2012-07-16       Impact factor: 3.441

4.  Anaplasma phagocytophilum APH_1387 is expressed throughout bacterial intracellular development and localizes to the pathogen-occupied vacuolar membrane.

Authors:  Bernice Huang; Matthew J Troese; Shaojing Ye; Jonathan T Sims; Nathan L Galloway; Dori L Borjesson; Jason A Carlyon
Journal:  Infect Immun       Date:  2010-03-08       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.